Storys zum Thema Enterprises

Folgen
Keine Story zum Thema Enterprises mehr verpassen.
Filtern
  • 02.05.2011 – 11:03

    Alliance of Civilizations

    Qatar Will Host on May 3-4 the First Pre Forum of Civil Society of the Alliance of Civilizations

    Doha, Qatar and New York (ots/PRNewswire) - It will be the first major event in the run-up to the December, 2011 Fourth Annual Forum of the Alliance of Civilizations, a major initiative affiliated with the United Nations. The Alliance of Civilizations seeks to address misunderstanding and fear from the Other and build trust and confidence that stems from mutual ...

  • 29.04.2011 – 15:01

    PopCap Games

    PopCap Games Acquires ZipZapPlay

    Dublin (ots/PRNewswire) - PopCap Games, the worldwide leader in casual games, today announced that it has signed an agreement to acquire ZipZapPlay, a social games company based in San Francisco, California. With the acquisition, PopCap increases its Facebook games lineup, establishes a social studio in Silicon Valley, and positions itself for further growth and continued success in one of the hottest digital games categories. Financial terms of the acquisition were not ...

  • 28.04.2011 – 09:40

    Novo Nordisk

    Novo Nordisk Increased Operating Profit by 24% in the First Quarter of 2011 (28 April 2011)

    Bagsvaerd, Denmark (ots/PRNewswire) - Sales increased by 15% in Danish kroner and by 11% in local currencies. - Sales of modern insulins increased by 14% (11% in local currencies). - Victoza(R) sales of DKK 1,098 million (growth of 191% in local currencies). - Sales of NovoSeven(R) increased by 6% (4% in local currencies). - Sales in North America increased by 16% (14% ...

  • 26.04.2011 – 16:57

    Bayer Animal Health

    Bayer to Expand Companion Animal Portfolio With Two New EU Product Approvals

    Monheim, Germany (ots/PRNewswire) - Bayer today announced that the European Commission has approved two new companion animal products: Veraflox(R) (pradofloxacin) and Procox(R) (emodepside and toltrazuril). Veraflox(R) is the first next-generation veterinary fluoroquinolone antibiotic for the treatment of bacterial infection in cats and dogs. Procox(R) is the first and ...

  • 26.04.2011 – 10:03

    WinSoft International

    PagePlus X5 Now Available in 7 Languages

    Grenoble, France (ots/PRNewswire) - WinSoft International Announces the Immediate Availability of PagePlus X5, the Affordable Easy-to-use Desktop Publisher From Serif, in 7 Languages. Creating professional print materials for small businesses working in Czech, Dutch, Italian, Polish, Russian, Spanish and Swedish has just gotten a little bit easier with the release by WinSoft International of 7 localized versions of the ...

  • 21.04.2011 – 16:07

    paddypower.com

    Betting on Royal Wedding Goes into Overdrive

    London (ots/PRNewswire) - With excitement around next week's Royal Wedding reaching fever pitch, leading betting firm Paddy Power have reported record levels of betting on the Royal nuptials from people around the world. To view the Multimedia News Release, please click: http://multivu.prnewswire.com/mnr/prne/paddypower/48904/ So far almost 5,000 bets have been wagered with the bookmaker on a diverse range of Royal ...

  • 19.04.2011 – 01:03

    Eisai Limited

    Zebinix(R) Now Available in Greece

    Hatfield, England (ots/PRNewswire) - Zebinix(R) (eslicarbazepine acetate), an add-on (adjunctive) therapy for adults with partial-onset seizures, with or without secondary generalisation (where the seizure extensively affects consciousness of the patients by propagation to both sides of the brain), has recently been launched in Greece by Arriani Pharmaceuticals, Eisai's chosen partner in Greece. In April 2009, the European Commission approved Zebinix(R) based on data showing ...

  • 13.04.2011 – 09:00

    Helsinn Healthcare SA

    Helsinn and Taiho Pharmaceutical Co., Ltd. to Extend Relationship

    Lugano, Switzerland/Tokyo, Japan (ots) - License Agreement for Japan on Potential New Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) Helsinn Group of Switzerland and Taiho Pharmaceutical Co., Ltd., Japanese licensee of Helsinn's second generation 5-HT3 receptor antagonist palonosetron, announce today the signing on April 12, of a licensing agreement granting Taiho the development and ...